Literature DB >> 9484397

Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1-weighted MRI.

A Gass1, M Filippi, M E Rodegher, A Schwartz, G Comi, M G Hennerici.   

Abstract

We analyzed the prevalence of severely hypointense lesions on T1-weighted MRI in the brainstem, spinal cord, and optic nerve from 65 patients with MS. About half of 1,274 supratentorial lesions were classified as severely hypointense. Severe hypointensity was not seen in the optic nerve and spinal cord, and in only one of 168 chronic brainstem lesions. Tissue destruction in the brainstem, spinal cord, and optic nerve of MS patients does not usually result in severely hypointense lesions.

Entities:  

Mesh:

Year:  1998        PMID: 9484397     DOI: 10.1212/wnl.50.2.548

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T.

Authors:  Samantha By; Robert L Barry; Alex K Smith; Bailey D Lyttle; Bailey A Box; Francesca R Bagnato; Siddharama Pawate; Seth A Smith
Journal:  Magn Reson Med       Date:  2017-05-05       Impact factor: 4.668

2.  Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes.

Authors:  Maria Di Gregorio; Lorenzo Gaetani; Paolo Eusebi; Piero Floridi; Antonella Picchioni; Giovanni Rosi; Andrea Mancini; Chiara Floridi; Francesca Baschieri; Lucia Gentili; Paola Sarchielli; Paolo Calabresi; Massimiliano Di Filippo
Journal:  J Neurol       Date:  2018-01-11       Impact factor: 4.849

Review 3.  Magnetic resonance imaging in immune-mediated myelopathies.

Authors:  M J Wendebourg; S Nagy; T Derfuss; K Parmar; R Schlaeger
Journal:  J Neurol       Date:  2019-01-29       Impact factor: 4.849

Review 4.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

5.  Disease-modifying Therapies for Multiple Sclerosis.

Authors:  John R. Corboy; Douglas S. Goodin; Elliot M. Frohman
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

6.  Bedside tested ocular motor disorders in multiple sclerosis patients.

Authors:  G Servillo; D Renard; G Taieb; P Labauge; S Bastide; M Zorzon; G Castelnovo
Journal:  Mult Scler Int       Date:  2014-04-30

7.  Evaluating single-point quantitative magnetization transfer in the cervical spinal cord: Application to multiple sclerosis.

Authors:  Alex K Smith; Samantha By; Bailey D Lyttle; Richard D Dortch; Bailey A Box; Lydia J Mckeithan; Saakshi Thukral; Francesca Bagnato; Siddharama Pawate; Seth A Smith
Journal:  Neuroimage Clin       Date:  2017-07-14       Impact factor: 4.881

8.  Pre-contrast T1-weighted imaging of the spinal cord may be unnecessary in patients with multiple sclerosis.

Authors:  Nico Sollmann; Jan S Kirschke; Isabelle Riederer; Mark Mühlau; Claus Zimmer; Magaly Gutbrod-Fernandez
Journal:  Eur Radiol       Date:  2021-06-09       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.